UDCA treat MENT made easy
Each 5 ml contains Ursodeoxycholic Acid 125 mg In a flavoured Sorbitol base q.s. Colour - Sunset Yellow FCF
Neonatal Cholestasis, Primary Biliary Atresia and viral Hepatitis
10- 15 mg/ kg BID
Oral administration of udcament increases this fraction in a dose related manner, to become the major biliary acid, replacing/displacing toxic concentrations of endogenous hydrophobic bile acids that tend to accumulate in cholestatic liver disease.
It should be stored at room temperature away from light
Some products that may interact with this drug include: Antacids, Cholestyramine, Colestipol, Oestrogens.
Diarrhea, Indigestion, Headache, Nausea or Vomiting, Back pain, Bloody and cloudy urine, Black or tarry stools, Unusual bleeding or bruising, Frequent and/or painful urination, Fever and cough, Hair loss, Swelling of eyelids, face, lips, tongue.